Voglibose - C10h21no7 Powder Alpha-glucosidase Inhibitor For Diabetes Treatment Lowers Post-prandial Blood Glucose Levels

CAS number
83480-29-9

Chemical Formula
C10H21NO7

For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications. Voglibose an alpha-glucosidase inhibitor is a synthetic compound with potent and enduring therapeutic efficacies against disorders of sensory motor and autonomic nerve systems due to diabetes mellitus. The drug was approved in Japan in 1994 for the treatment of diabetes and it is under further investigation by Takeda for the treatment of impaired glucose tolerance. Alpha-glucosidase inhibitors are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of complex carbohydrates (such as starch). Complex carbohydrates are normally converted into simple sugars (monosaccharides) which can be absorbed through the intestine. Hence alpha-glucosidase inhibitors reduce the impact of complex carbohydrates on blood sugar.